Related Experiment Video

Updated: Apr 20, 2026

Rapid Detection of Neurodevelopmental Phenotypes in Human Neural Precursor Cells NPCs
10:47

Rapid Detection of Neurodevelopmental Phenotypes in Human Neural Precursor Cells NPCs

Published on: March 2, 2018

10.7K

Ankyrin repeat-rich membrane spanning (ARMS)/Kidins220 scaffold protein regulates neuroblastoma cell proliferation

Heekyung Jung1, Joo-Hyun Shin1, Young-Seok Park1

  • 1Department of Oral Anatomy, School of Dentistry and Dental Research Institute, Seoul National University, Seoul 110-749, Korea.

Molecules and Cells
|November 21, 2014
PubMed

Insights

Knockdown of ankyrin repeat-rich membrane spanning (ARMS) scaffold protein inhibits neuroblastoma cell proliferation by slowing the cell cycle. This occurs via upregulation of p21, decreasing cyclin D1 and CDK4, and reducing pRb hyperphosphorylation.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • Cell proliferation is regulated by cell-cycle proteins like cyclins and cyclin-dependent kinases (CDKs).
  • Ankyrin repeat-rich membrane spanning (ARMS) scaffold protein (Kidins 220) is a known downstream target of neurotrophin and ephrin receptors.
  • ARMS/Kidins220 functions as a signaling platform in the nervous and vascular systems.

Purpose of the Study:

  • To investigate the role of ARMS/Kidins220 in cell proliferation and cell-cycle progression.
  • To elucidate the molecular mechanisms by which ARMS/Kidins220 influences tumor cell growth.

Main Methods:

  • ARMS/Kidins220 knockdown in mouse neuroblastoma cells.
  • Cell-cycle analysis to assess proliferation rates.
  • Western blotting to evaluate protein levels (p21, cyclin D1, CDK4, pRb).

Main Results:

  • ARMS/Kidins220 knockdown significantly inhibited mouse neuroblastoma cell proliferation.
  • Cell-cycle analysis revealed a slowdown in the G1 phase.
  • This was associated with increased p21 (CDK inhibitor) and decreased cyclin D1 and CDK4 protein levels.
  • Reduced hyperphosphorylation of pRb was observed.

Conclusions:

  • ARMS/Kidins220 plays a novel role in regulating tumor cell proliferation.
  • It acts as a signaling platform influencing cell-cycle progression at the G1 phase.
  • ARMS/Kidins220 is a potential target for cancer therapy.
Keywords:
cell cyclecyclinneurotrophinproliferationscaffold protein

More Related Videos

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter11:32

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter

Published on: March 27, 2020

7.5K
Visualizing Neuroblast Cytokinesis During C. elegans Embryogenesis09:52

Visualizing Neuroblast Cytokinesis During C. elegans Embryogenesis

Published on: March 12, 2014

12.5K

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
39.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.5K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.3K
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
3.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.2K